- Coordinator
- Centre National De La Recherche Scientifique CNRS, France
- Runs
- 1 October 2024 to 31 March 2026
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101158105
What the project is doing
In the project's own words, from its summary on CORDIS.
Extracellular vesicles (EVs) have emerged as pivotal regulators of both physiological homeostasis and pathological conditions, including cancer and regenerative diseases, and have recently been pinpointed as central effectors in the therapeutic capabilities of their parent cells. Nevertheless, the therapeutic market of EVs still has significant potential for further development. Specifically, EV production methods that deliver robust, scalable and high-yield productions, if possible with the minimum cell material, are still unattainable.
Besides, existing technologies are not adequately versatile to accommodate different types of producer cells, which is of particular relevance, given that the biological makeup of the EVs, and in turn their therapeutic potential, strongly depend on the state of the parental cells when stimulated. Here, we aim to integrate tight control of produced cells configuration with high-throughput production of EVs in a streamlined system.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Centre National De La Recherche Scientifique CNRS | Paris | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI